Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous aminophylline for prevention of post-dural puncture headache after spinal anesthesia in elective orthopedic surgery
IRCT20221227056940N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Aminophylline plus spinal anesthesia with Placebo saline plus spinal anesthesia (2 arms). Primary endpoints: Time of headache onset, Headache severity and 1 more. Started Sep 2025; status: completed.
02
Drugs
aminophylline
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20221227056940N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221227056940N3.